These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9858968)
21. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy. Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288 [TBL] [Abstract][Full Text] [Related]
22. Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators. Streitner F; Kuschyk J; Veltmann C; Mahl E; Dietrich C; Schimpf R; Doesch C; Streitner I; Wolpert C; Borggrefe M Europace; 2011 May; 13(5):668-74. PubMed ID: 21156679 [TBL] [Abstract][Full Text] [Related]
23. A prophylactic ICD? Who are the patients? What is the device? Nisam S Europace; 2001 Oct; 3(4):269-74. PubMed ID: 11678383 [No Abstract] [Full Text] [Related]
24. A comprehensive approach to management of ventricular arrhythmias. Kusumoto F Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192 [TBL] [Abstract][Full Text] [Related]
25. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices. Doherty JU; Fuchs S; Tecce MA Geriatrics; 2000 Aug; 55(8):26-8, 31-2, 35-6. PubMed ID: 10953684 [TBL] [Abstract][Full Text] [Related]
26. The interpretation and clinical application of data from trials on sudden cardiac death. Myerburg RJ; Mitrani R; Interian A; Simmons J; Kloosterman M; Castellanos A J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():95-102. PubMed ID: 10590495 [No Abstract] [Full Text] [Related]
27. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator. Prystowsky EN Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369 [TBL] [Abstract][Full Text] [Related]
28. [Indications for implantable automatic defibrillators]. Leenhardt A; Coumel P; Thomas O; Leclercq JF; Slama R Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):61-6. PubMed ID: 7944867 [TBL] [Abstract][Full Text] [Related]
29. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator. O'Brien BJ; Yee R Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279 [No Abstract] [Full Text] [Related]
30. Treatment approaches for patients with sustained VT/VF. Mitchell LB; Roy D Can J Cardiol; 2000 Jun; 16 Suppl C():23C-5C. PubMed ID: 10887274 [No Abstract] [Full Text] [Related]
31. The utilization of the implantable defibrillator--a European enigma. Camm AJ; Nisam S Eur Heart J; 2000 Dec; 21(24):1998-2004. PubMed ID: 11102250 [No Abstract] [Full Text] [Related]
32. Ventricular tachycardia and ventricular fibrillation. Srivathsan K; Ng DW; Mookadam F Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116 [TBL] [Abstract][Full Text] [Related]
33. Antiarrhythmic therapy for the prevention of sudden cardiac death. Cairns J; Kerr C; Teo K Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276 [No Abstract] [Full Text] [Related]
34. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation. Kuck KH Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082 [No Abstract] [Full Text] [Related]
35. [10 years of therapy with implantable defibrillators--observation in 353 patients]. Trappe HJ; Wenzlaff P; Klein H; Pfitzner P; Fieguth HG; Kielblock B; Lichtlen PR Z Kardiol; 1995 Mar; 84(3):222-31. PubMed ID: 7732715 [TBL] [Abstract][Full Text] [Related]
36. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death. Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population. Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231 [TBL] [Abstract][Full Text] [Related]
38. Over 10 years with an implantable cardioverter-defibrillator - a long term follow-up of 60 patients. Sterliński M; Przybylski A; Gepner K; Syska P; Maciag A; Lewandowski M; Kowalik I; Pytkowski M; Sitkowska-Rysiak E; Lichomski J; Szwed H; Sadowski Z Kardiol Pol; 2010 Sep; 68(9):1023-9. PubMed ID: 20859894 [TBL] [Abstract][Full Text] [Related]
39. [Regarding the French Society of Cardiologists' guidelines on the indications for implantable automatic ventricular defibrillators]. Daubert JC Arch Mal Coeur Vaiss; 2006 Feb; 99(2):93-4. PubMed ID: 16555690 [No Abstract] [Full Text] [Related]
40. Primary prevention of sudden cardiac death: one step forwards and one step backwards. Cain ME Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]